Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px

Deals > All

Total search results: 9509 | Ordered by Date (descending)
1 2 3 ... 94 95 96  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
BioNTech–Consilium: public relations, 201807 service existent international media relations + European IR by CSC 2018-07-10
BioNTech–Roivant: LNP technology, 201807– license excl to apply Genevant’s LNP delivery technology to 5 of BioNTech’s oncology programs 2018-07-10
BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic 2018-07-10
BioNTech–Westwicke Partners: public relations, 201807 service existent US IR by Westwicke Partners 2018-07-10
Pionyr Immunotherapeutics–Minapharm: biopharma production, 201807– supply service cell line + process dev + prod of 2nd therap antibody by ProBioGen 2018-07-10
Roivant–BioNTech: mRNA therapeutics, 201807– collab strategic partnership to develop 5 products for rare disease with Genevant 2018-07-10
Summit–CARB-X: grant, 201807– grant $2m + optional $2.5m for antibiotics drug discovery for gonorrhoea using Discuva Platform 2018-07-10
Summit–Consilium: public relations, 201807 service existent by CSC 2018-07-10
Abingworth–Goodwin Procter: legal services, 201807 supply service legal counsel for $315m Abingworth Bioventures VII Fund 2018-07-09
Abingworth–SEVERAL: investment, 201807 final closing of $315m Abingworth Bioventures VII Fund 2018-07-09
Yposkesi–Andrew Lloyd Associates: public relations, 201807 service existent by ALA 2018-07-09
Dynacure–Andera Partners: investment, 201807 financing round totalling €47m incl lead investor Andera Partners 2018-07-06
Dynacure–France (govt): investment, 201807 financing round totalling €47m incl co-investor Bpifrance 2018-07-06
Dynacure–Idinvest Partners: investment, 201807 financing round totalling €47m incl co-investor Idinvest Partners 2018-07-06
Dynacure–Kurma: investment, 201807 financing round totalling €47m incl co-investor Kurma Partners 2018-07-06
Dynacure–Pontifax: investment, 201807 financing round totalling €47m incl co-investor Pontifax 2018-07-06
Dynacure–SEVERAL: investment, 201807 financing round €47m led by Andera Partners + incl Pontifax + Bpifrance + Kurma + IdInvest 2018-07-06
Netbiotix–Auriga: investment, 201807 financing round Series A totalling €7.5m incl lead investor Auriga Partners 2018-07-05
Netbiotix–Biocodex: investment, 201807 financing round Series A totalling €7.5m incl co-investor Biocodex 2018-07-05
Netbiotix–SEVERAL: investment, 201807 financing round Series A €7.5m led by Auriga Partners + incl Biocodex 2018-07-05
Basilea–Coulter Partners: recruitment services, 201807 supply service placement of Gerrit Hauck as new CTO of Basilea Pharmaceutica Intl Ltd 2018-07-04
Laboratoire de Bromatologie de l’Ouest–Eurofins: investment, 201807 acquisition of LBO by Eurofins 2018-07-03
Lactotronic–Bruker Corp: investment, 201807 acquisition €na of Lactotronic BV by Bruker 2018-07-03
Pharma Omnium–NuPharm: investment, 201807 acquisition €na of Laboratoire Biodim from Pharma Omnium 2018-07-03
Abcam–Instinctif Partners: public relations, 201807 service existent by Instinctif 2018-07-02
Telix–Abzena: biopharmaceuticals, 201807– supply $5.9m strategic manufacturing + bioconjugation agreement 2018-07-02
VarmX–BioGeneration Ventures: investment, 201807 financing round Series A totalling €7.5m incl lead + existing investor BGV 2018-07-02
VarmX–InnovationQuarter (NL): investment, 201807 financing round Series A totalling €7.5m incl existing co-investor InnovationQuarter Capital 2018-07-02
VarmX–LifeSpring: public relations, 201807 service existent by LifeSpring Communications 2018-07-02
VarmX–Netherlands (govt): credit, 201807– Innovation Credit €5m from RVO.nl 2018-07-02
VarmX–SEVERAL: investment, 201807 financing round Series A €7.5m with lead + existing investor BGV plus existing investor InnovationQuarter 2018-07-02
AMS Biotechnology–Univ Strathclyde: drug screening technology, 201807 collab establishment of joint venture ScreenIn3D in Glasgow 2018-07-01
JnJ–Medivir: antiviral, –201806 license for simeprevir to Janssen Pharmaceuticals Inc TERMINATED 6/18 2018-06-30
Kymab–1AB Media: public relations, 201806 service existent US media relations by 1AB Media 2018-06-28
Kymab–Consilium: public relations, 201806 service existent UK media relations by CSC 2018-06-28
Mérieux–Deinove: antibiotics, 201806– collab antibotics drug discovery of bioMérieux + Deinove + AGIR project 2018-06-28
ProZyme–Agilent: investment, 201806– acquisition €na of ProZyme Inc by Agilent ANNOUNCED 2018-06-28
Bruker Corp–Cytosurge: cell analysis technology, 201806 collab product integration FluidFM techn on BioScope Resolve AMF for single cell analysis 2018-06-27
Nouscom–Minapharm: cell line, 201806– license to ProBioGen’s AGE1.CR duck cell line for production of viral vectored vaccines 2018-06-26
Exosome Diagnostics–Bio-Techne: investment, 201806– acquisition $250m cash + $325m milestones of Exosome Dx by Bio-Techne ANNOUNCED 2018-06-25
Exosome Diagnostics–Goodwin Procter: legal services, 201806 supply service legal counsel with regard to acquisition of Exosome Dx by Bio-Techne Corp 2018-06-25
Exosome Diagnostics–Moelis: financial services, 201806 supply service financial advisor with regard to acquisition of Exosome Dx by Bio-Techne Corp 2018-06-25
NodThera–5AM Ventures: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Consilium: public relations, 201806 service existent by CSC 2018-06-25
NodThera–Epidarex Capital: investment, 201806 financing round Series A totalling £28m ($40m) incl existing co-investor Epidarex Capital 2018-06-25
NodThera–F-Prime: investment, 201806 financing round Series A totalling £28m ($40m) incl co-investor F-Prime Capital Partners 2018-06-25
NodThera–Selvita: investment, 201806 existing investor 2018-06-25
NodThera–SEVERAL: investment, 201806 financing round Series A £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Sofinnova: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
Univ Missouri–Bruker Corp: mass spectrometer, 201806 supply existent timsTOF Pro system at Univ of Missouri in Columbia MO 2018-06-25
Autolus–JW Communications: public relations, 201806 service existent media relations by JW Communications 2018-06-22
Autolus–SA Noonan Communications: public relations, 201806 service existent IR by SA Noonan 2018-06-22
Curetis–Goetzpartners: investor conference, 201806 supply service Curetis presents at Goetzpartners Healhlcare Day 2018 in London 2018-06-22
AdoRx–Charlotte Street Partners: public relations, 201806 service existent by CSP 2018-06-21
AdoRx–Epidarex Capital: investment, 201806 1st financing round totalling $10m from Epidarex Capital + CRT Pioneer Fund 2018-06-21
AdoRx–SEVERAL: investment, 201806 1st financing round $10m from Epidarex Capital + CRT Pioneer Fund 2018-06-21
AdoRx–Sixth Element Capital: investment, 201806 1st financing round totalling $10m from Epidarex Capital + CRT Pioneer Fund 2018-06-21
PhoreMost–o2h Discovery: drug discovery, 201806– collab using o2h’s medicinal chemistry to advance drug discovery projects of PhoreMost 2018-06-21
Erytech–JMP Securities: investor conference, 201806 supply service Erytech presents at JMP Securities 2018 Life Sciences Conference NY 2018-06-20
iTeos Therapeutics–6 Dimensions Capital: investment, 201806 financing round Series B totalling €64m incl new + co-investor 6 Dimensions Capital 2018-06-20
iTeos Therapeutics–Belgium (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SFPI 2018-06-20
iTeos Therapeutics–Curative Ventures: investment, 201806 financing round Series B totalling €64m incl new + co-investor Curative Ventures 2018-06-20
iTeos Therapeutics–Fund+: investment, 201806 financing round Series B totalling €64m incl existing + co-investor Fund+ 2018-06-20
iTeos Therapeutics–HBM: investment, 201806 financing round Series B totalling €64m incl new + co-investor HBM Partners 2018-06-20
iTeos Therapeutics–MPM Capital: investment, 201806 financing round Series B totalling €64m incl new + lead investor MPM Capital 2018-06-20
iTeos Therapeutics–SEVERAL: investment, 201806 financing round Series B €64m led by MPM Capital 2018-06-20
iTeos Therapeutics–Univ Leuven: investment, 201806 financing round Series B totalling €64m incl existing + co-investor VIVES II 2018-06-20
iTeos Therapeutics–Wallonia (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SRIW 2018-06-20
Labstep–SEVERAL: investment, 201806 financing round £1m from angel investors 2018-06-20
TG Therapeutics–Novimmune: bispecific antibody, 201806– collab + excl license option ww for CD47/CD19 antibody NI-1701 (TG-1801) 2018-06-20
Foundation Medicine–Roche: investment, 201806– acquisition all remaining shares for $2.4b in cash at $137/share 2018-06-19
Freeline Therapeutics–JW Communications: public relations, 201806 service existent by JW Communications 2018-06-19
Freeline Therapeutics–SEVERAL: investment, 201806 financing round Series B £88.4m with £85m from Syncona Ltd + £3.4m from UCL TF 2018-06-19
Freeline Therapeutics–Univ College London: investment, 201806 financing round Series B totalling £88.4m incl £3.4m from UCL TF 2018-06-19
Freeline Therapeutics–Wellcome Trust: investment, 201806 financing round Series B totalling £88.4m incl £85m from Syncona Ltd 2018-06-19
Galmed–LifeSci: public relations, 201806 service existent by LifeSci Advisors 2018-06-19
UgiSense–SEVERAL: investment, 201806 second financing round 2018-06-19
Galmed–SEVERAL: investment, 201806 public offering $75m+$11.25m with 5m+750k ordinary shares at $15/share 2018-06-18
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics 2018-06-16
Noxxon–SEVERAL: credit, 201806– convertible bond €380k from existing investors 2018-06-15
Onxeo–Nice & Green: investment, 201806–201903 equity line financing up to €5.4m with up to 4.7new shares 2018-06-15
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec 2018-06-15
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share 2018-06-14
Bruker Corp–William Blair: investor conference, 201806 supply service Bruker presents at William Blair Annual Growth Stock Conference in Chicago 2018-06-13
Remote Diagnostic Technologies–Philips: investment, 201806 acquisition €na of RDT by Philips 2018-06-13
Andrew Alliance–Omega Advisors: investment, 201806 financing round Series C totalling $14m incl Omega Funds 2018-06-12
Andrew Alliance–SEVERAL: investment, 201806 financing round Series C $14m incl Tecan + Waters + Inpeco + Rancilio Cube + Sam Eletr + Omega Funds 2018-06-12
Andrew Alliance–Tecan: investment, 201806 financing round Series C totalling $14m incl Tecan Group 2018-06-12
Andrew Alliance–Waters: investment, 201806 financing round Series C totalling $14m incl Waters Corp 2018-06-12
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Univ Jena–ACD/Labs: cheminformatics, 201806 supply ACD/Spectrus Processor + ACD/NMR Workbook Suite + ACD/MS Workbook Suite 2018-06-12
Univ Jena–Bruker Corp: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Shimadzu: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Thermo Fisher: mass spectrometer, 201806 supply existent 2018-06-12
RSP Systems–SEVERAL: investment, 201806 financing round Series B first closing €6.5m incl family offices + private investors 2018-06-11
Bruker Corp–Leucadia: investor conference, 201806 supply service Bruker presents at Jefferies Healthcare Conference in New York 2018-06-07
Evotec–Deutsche Bank: investor conference, 201806 supply service Evotec presents at dbAccess Berlin Conference 2018-06-07
Kandy Therapeutics–Consilium: public relations, 201806 service existent by CSC 2018-06-07
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
1 2 3 ... 94 95 96  next pagenext page



Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px

» top